Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis

Diabetologia

Volumn 55, Issue 11, 2012, Pages 3021-3028

  Kehlenbrink, S ^a   Koppaka, S ^a   Martin, M ^a   Relwani, R ^a   Cui, M H ^a   Hwang, J H ^a   Li, Y ^a   Basu, R ^b   Hawkins, M ^a   Kishore, P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Diabetes mellitus; Glucose production; Glycogen; Hyperglycaemia; NEFA; Non esterified fatty acids

Indexed keywords

CARBON 13; FATTY ACID; GLUCOSE; GLYCOGEN; GROWTH HORMONE; INSULIN; SOMATOSTATIN;

ADULT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIET RESTRICTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VOLUNTEER;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FATTY ACIDS, NONESTERIFIED; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; GLYCOGEN; GLYCOGENOLYSIS; HUMAN GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; INSULIN; LIVER; MALE; SOMATOSTATIN;

EID: 84867574113     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2662-6     Document Type: Article

References (45)

1. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulindependent diabetic subjects. J Clin Invest 74:1238-1246
2. DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
3. Nagasaka S, Tokuyama K, Kusaka I et al (1999) Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes 48:1054-1060
4. Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H (2002) Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. Diabetes 51:2179-2189
5. MevorachM, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L (1998) Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 102:744-753
6. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA (1998) Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: Evidence for a concentration-dependent defect in uptake. Diabetes 47:1735-1747
7. Antras-Ferry J, Le Bigot G, Robin P, Robin D, Forest C (1994) Stimulation of phosphoenolpyruvate carboxykinase gene expression by fatty acids. Biochem Biophys Res Commun 203:385-391
8. Williamson JR, Kreisberg RA, Felts PW (1966) Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci U S A 56:247-254
9. Kehlenbrink S, Tonelli J, Koppaka S, Chandramouli V, Hawkins M, Kishore P (2009) Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production. Am J Physiol Endocrinol Metab 297:E165-E173
10. Kishore P, Tonelli J, Koppaka S et al (2006) Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes. Diabetes 55:1761-1768
11. Hawkins M, Tonelli J, Kishore P et al (2003) Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes. Diabetes 52:2748-2758
12. Kishore P, Li W, Tonelli J, et al (2010) Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages. Sci Transl Med 2: 20ra15
13. Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924
14. Balent B, Goswami G, Goodloe G et al (2002) Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann N Y Acad Sci 967:535-543
15. Brooker HR, Mareci TH, Mao JT (1987) Selective Fourier transform localization. Magn Reson Med 5:417-433
16. Rossetti L, Chen W, Hu M, Hawkins M, Barzilai N, Efrat S (1997) Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele. Am J Physiol 273:E743-E750
17. Hovorka R, Jayatillake H, Rogatsky E, Tomuta V, Hovorka T, Stein DT (2007) Calculating glucose fluxes during meal tolerance test: A new computational approach. Am J Physiol Endocrinol Metab 293:E610-E619
18. Basu R, Barosa C, Basu A et al (2011) Transaldolase exchange and its effects on measurements of gluconeogenesis in humans. Am J Physiol Endocrinol Metab 300:E296-E303
19. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC (1996) Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98:378-385
20. Kishore P, Boucai L, Zhang K et al (2011) Activation of KATP channels suppresses glucose production in humans. J Clin Invest 121:4916-4920
21. Sikuler E, Polio J, Groszmann RJ, Hendler R (1987) Glucagon and insulin metabolism in a portal-hypertensive rat model. Am J Physiol 253:G110-G115
22. Jenssen T, Nurjhan N, Consoli A, Gerich JE (1990) Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 86:489-497
23. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI (1998) Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101:1203-1209
24. Rossetti L, Giaccari A, Barzilai N, Howard K, Sebel G, Hu M (1993) Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J Clin Invest 92:1126-1134
25. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD (1998) Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 47:523-529
26. Aiston S, Andersen B, Agius L (2003) Glucose 6-phosphate regulates hepatic glycogenolysis through inactivation of phosphorylase. Diabetes 52:1333-1339
27. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024
28. van de Werve G, Lange A, Newgard C, Mechin MC, Li Y, Berteloot A (2000) New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system. Eur J Biochem 267:1533-1549
29. Lam TK, van de Werve G, Giacca A (2003) Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 284:E281-E290
30. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW (1997) Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46:1768-1774
31. Roden M, Stingl H, Chandramouli V et al (2000) Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49:701-707
32. Stingl H, Krššák M, Krebs M et al (2001) Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 44:48-54
33. Boden G, Chen X, Capulong E, Mozzoli M (2001) Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50:810-816
34. Shah P, Vella A, Basu A et al (2003) Elevated free fatty acids impair glucose metabolism in women. Diabetes 52:38-42
35. DeFronzo RA, Abdul-Ghani MA (2011) Preservation of beta-cell function: The key to diabetes prevention. J Clin Endocrinol Metab 96:2354-2366
36. Krssak M, Brehm A, Bernroider E et al (2004) Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 53:3048-3056
37. Kacerovsky M, Jones J, Schmid AI et al (2011) Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes 60:1752-1758
38. Cline GW, Rothman DL, Magnusson I, Katz LD, Shulman GI (1994) 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J Clin Invest 94:2369-2376
39. Hwang JH, Perseghin G, Rothman DL et al (1995) Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 95:783-787
40. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.NEngl JMed 322:223-228
41. Agius L (2008) Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 414:1-18
42. Agius L, Peak M, Newgard CB, Gomez-Foix AM, Guinovart JJ (1996) Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis. J Biol Chem 271:30479-30486
43. Clore JN, Stillman J, Sugerman H (2000) Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 49:969-974
44. Caro JF, Triester S, Patel VK, Tapscott EB, Frazier NL, Dohm GL (1995) Liver glucokinase: Decreased activity in patients with type II diabetes. Horm Metab Res 27:19-22
45. Seoane J, Gomez-Foix AM, O'Doherty RM, Gomez-Ara C, Newgard CB, Guinovart JJ (1996) Glucose 6-phosphate produced by glucokinase, but not hexokinase I, promotes the activation of hepatic glycogen synthase. J Biol Chem 271:23756-23760